Elanco Sells Lotilaner Rights to Blackstone, Boosts Debt Paydown
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the sale of certain future tiered royalties and commercial milestones associated with XDEMVY® (lotilaner ophthalmic solution) 0.25%, for...